Lymphedema secondary to melanoma treatments: diagnosis, evaluation, and treatments

microleakage evaluation in regard to cavo-surface designs & treatments

چکیده ندارد.

Lndication and Evolution of Surgical Treatments in Lymphedema

The anatomy and physiology of the lymphatic system of the extremities is reviewed, with special refe;ence to increasing knowledge from lymphan­giography.  The surgical treatment of primary lymphoedema of the extremities by transposition of superficial lym­phatics into the deep compartment of the limb em­ploying a buried "Shaved" skin flap "Thompson" operaion was ,used in 2 cases with excellent...

Melanoma: Treatments and Resistance

New treatments for metastatic melanoma.

CMAJ 2014.001:10.1503 /cmaj.130989 U ntil 2010, the median survival of pa­ tients with metastatic melanoma was about seven months, and only 6% of patients survived to five years. Chemotherapy with dacarbazine was the standard of care, al­ though it had not been proven to improve patient survival.1 Randomized controlled trials have now shown that both kinase inhibitors and immunotherapeutic anti...

Melanoma: tumor microenvironment and new treatments*

In the recent past years, many discoveries in the tumor microenvironment have led to changes in the management of melanoma and it is rising up hopes, specially, to those in advanced stages. FDA approved seven new drugs from 2011 to 2014. They are: Vemurafenib, Dabrafenib and Trametinib, kinases inhibitors used for patients that have BRAFV600E mutation; Ipilimumab (anti-CTLA4), Pembrolizumab (an...